{"id":16991,"date":"2021-11-22T12:48:38","date_gmt":"2021-11-22T12:48:38","guid":{"rendered":"https:\/\/rhepa.se\/?page_id=16991"},"modified":"2025-03-01T21:10:27","modified_gmt":"2025-03-01T21:10:27","slug":"marknadssonderingar","status":"publish","type":"page","link":"https:\/\/rhepa.se\/en\/marknadssonderingar\/","title":{"rendered":"Market soundings"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Marknadssonderingar\n<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Nedanst\u00e5ende f\u00f6rh\u00e5llningsregler ska iakttas f\u00f6r marknadsakt\u00f6rer som kontaktar Rhenman & Partners Asset Management AB f\u00f6r att g\u00f6ra en marknadssondering* i enlighet med marknadsmissbruksreglerna, MAR (Market Abuse Regulation).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Rhenman & Partners Asset Management AB, \u201dRhenman & Partners\u201d f\u00f6rvaltar p\u00e5 uppdrag av FundRock Management Company S.A., Luxemburg, portf\u00f6ljen i den i Luxemburgregistrerade fonden Rhenman Equity Healthcare L\/S. [Som motpart vid transaktioner anges Rhenman Healthcare Equity L\/S som allts\u00e5 f\u00f6retr\u00e4ds av Rhenman & Partners.]<\/p>

Med h\u00e4nvisning till MAR och till vad som sagts ovan, g\u00e4ller f\u00f6r marknadssonderingar till Rhenman & Partners f\u00f6r Rhenman Healthcare Equity L\/S r\u00e4kning f\u00f6ljande:<\/p>

1. Rhenman & Partners \u00e4r enbart intresserat av att ta emot marknadssonderingar som g\u00f6rs p\u00e5 ett s\u00e4tt som f\u00f6ljer MAR och av marknadsakt\u00f6rer som antagit egna interna processer f\u00f6r hur marknadssonderingar ska utf\u00f6ras.
2. Marknadssonderingar f\u00e5r enbart g\u00f6ras till Rhenman & Partners CIO, Henrik Rhenman.
3. Marknadssonderingar ska i f\u00f6rsta hand g\u00f6ras med anv\u00e4ndning av email. Henrik Rhenmans emailadress \u00e4r: henrik.rhenman@rhepa.com<\/a>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

*En marknadssondering kan beskrivas som en kommunikation av information innan offentligg\u00f6rande av en transaktion p\u00e5 kapitalmarknaden i syfte att utr\u00f6na om det finns intresse hos potentiella investerare att delta i den t\u00e4nkta transaktionen. Vid en s\u00e5dan kommunikation f\u00f6rekommer information om villkoren f\u00f6r transaktionen s\u00e5som dess t\u00e4nkta struktur, storlek och priss\u00e4ttning. Marknadssonderingar kan inneh\u00e5lla information som utg\u00f6r s.k. insiderinformation och annan icke offentliggjord information.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Marknadssonderingar Nedanst\u00e5ende f\u00f6rh\u00e5llningsregler ska iakttas f\u00f6r marknadsakt\u00f6rer som kontaktar Rhenman & Partners Asset Management AB f\u00f6r att g\u00f6ra en marknadssondering* i enlighet med marknadsmissbruksreglerna, MAR (Market Abuse Regulation). Rhenman & Partners Asset Management AB, \u201dRhenman & Partners\u201d f\u00f6rvaltar p\u00e5 uppdrag av FundRock Management Company S.A., Luxemburg, portf\u00f6ljen i den i Luxemburgregistrerade fonden Rhenman Equity Healthcare […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-16991","page","type-page","status-publish","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/rhepa.se\/en\/wp-json\/wp\/v2\/pages\/16991","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rhepa.se\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/rhepa.se\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/rhepa.se\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rhepa.se\/en\/wp-json\/wp\/v2\/comments?post=16991"}],"version-history":[{"count":23,"href":"https:\/\/rhepa.se\/en\/wp-json\/wp\/v2\/pages\/16991\/revisions"}],"predecessor-version":[{"id":27291,"href":"https:\/\/rhepa.se\/en\/wp-json\/wp\/v2\/pages\/16991\/revisions\/27291"}],"wp:attachment":[{"href":"https:\/\/rhepa.se\/en\/wp-json\/wp\/v2\/media?parent=16991"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}